Lorazepam
Lorazepam(中文:[[ ]]) is a short-acting benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant properties. It is used:
- In the short-term treatment of severe anxiety disorders;
- As a hypnotic in the short-term treatment of insomnia;
- As an anticonvulsant (particularly in the management of status epilepticus and febrile convulsions)
- As a sedative for those who are being mechanically ventilated
- Chemotherapy-induced nausea and vomiting
Pronunciation
Lorazepam 0.5mg
Lorazepam 1mg
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Lorazepam Tablet 0.5 mg | LORA01 | P1S1S3 & Part 1 Dangerous Drug |
| Lorazepam Tablet 1 mg | LORA02 | P1S1S3 & Part 1 Dangerous Drug |
| Lorazepam Tablet 2 mg | LORA03 | P1S1S3 & Part 1 Dangerous Drug |
Mechanism of Action
- Lorazepam is a benzodiazepine.
- Gama-Aminobutyric acid (GABA) is an inhibitory neurotransmitter, acting on the GABA receptors in the central nervous system (CNS), thus inhibiting the nerve impulses.
- It acts on the benzodiazepine receptors in the brain and the spinal cord. Benzodiazepine receptors in the CNS are linked with GABA receptors as a complex.
- Lorazepam by binding to the benzodiazepine receptors results in activation of the GABA-benzodiazepine receptor complex, resulting in inhibition of nerve impulses, overall depression of brain and spinal cord.
- The anticonvulsant properties of lorazepam come from binding to sodium channels.
Dosage
| Anxiety | By mouth
ADULT:
ELDERLY:
|
|---|---|
| Insomnia associated with anxiety | By mouth
ADULT: 1 – 2 mg daily, to be taken at bedtime |
| Acute panic attacks | By mouth
ADULT:
|
| Conscious sedation for procedures | By mouth
ADULT:
|
| Premedication | By mouth
|
| Status epilepticus
Febrile convulsions Convulsions due to poisoning |
By slow intravenous injection
CHILD 1 month – 11 years: 100 micrograms/kg (max. per dose 4 mg) for 1 dose, then 100 micrograms/kg after 10 minutes (max. per dose 4 mg) if required for 1 dose, to be administered into a large vein CHILD 12 – 17 years: 4 mg for 1 dose, then 4 mg after 10 minutes if required for 1 dose, to be administered into a large vein ADULT: 4 mg for 1 dose, then 4 mg after 10 minutes if seizures continue or recur |
| Chemotherapy-induced nausea and vomiting | By mouth
ADULTS: 1 to 2 mg may be added to antiemetic therapy with domperidone or metoclopramide for the prophylaxis of nausea and vomiting. The addition of lorazepam may be helpful in the prevention of anticipatory symptoms because of its anxiolytic, sedative and amnestic effects. |
Side Effects
Sedative drugs, including alprazolam, have been associated with an increased risk of death. Possible side effects include:
| Very common (>10% of incidence)
or Common (1-10% of incidence) |
|
| Infrequent (0.1 -1% of incidence) |
|
| Rare (<0.1% of incidence) |
|
Overdosage can produce CNS depression and coma.
Paradoxical reactions (the opposite of what is to be expected) may occur. Symptoms include
- aggression, rage
- mania, agitation, and restlessness
- hallucinations, inappropriate behavior
- twitches and tremor
Pharmacokinetics
| Oral bioavailability | Lorazepam is well absorbed after oral doses. |
|---|---|
| Onset of action | Peak plasma concentrations occur about 2 hours after an oral dose; and after 10 to 30 minutes when given as a rectal solution. |
| Metabolism | Lorazepam is metabolized in the liver |
| Elimination half-life |
Lorazepam is excreted in the urine. The half-life of Lorazepam ranges from 10 – 20 hours. |
